Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 23
Filter
Add more filters










Publication year range
1.
J Hazard Mater ; 443(Pt B): 130249, 2023 02 05.
Article in English | MEDLINE | ID: mdl-36332276

ABSTRACT

Brain volume decrease in the anterior cingulate cortex (ACC) after lead (Pb) exposure has been linked to persistent impairment of attention behavior. However, the precise structural change and molecular mechanism for the Pb-induced ACC alteration and its contribution to inattention have yet to be fully characterized. The present study determined the role of miRNA regulated synaptic structural and functional impairment in the ACC and its relationship to attention deficit disorder in Pb exposed mice. Results showed that Pb exposure induced presynaptic impairment and structural alterations in the ACC. Furthermore, we screened for critical miRNA targets responsible for the synaptic alteration. We found that miR-130, which regulates presynaptic vesicle releasing protein SNAP-25, was responsible for the presynaptic impairment in the ACC and attention deficits in mice. Blocking miR-130 function reversed the Pb-induced decrease in the expression of its presynaptic target SNAP-25, leading to the redistribution of presynaptic vesicles, as well as improved presynaptic function and attention in Pb exposed mice. We report, for the first time, that miR-130 regulating SNAP-25 mediates Pb-induced presynaptic structural and functional impairment in the ACC along with attention deficit disorder in mice.


Subject(s)
Attention Deficit Disorder with Hyperactivity , MicroRNAs , Animals , Mice , Attention Deficit Disorder with Hyperactivity/metabolism , Cognition , Gyrus Cinguli/metabolism , Lead/toxicity , Lead/metabolism , MicroRNAs/metabolism
2.
J Alzheimers Dis ; 87(2): 619-633, 2022.
Article in English | MEDLINE | ID: mdl-35367965

ABSTRACT

BACKGROUND: Early-life Pb exposure can cause behavioral and cognitive problems and induce symptoms of hyperactivity, impulsivity, and inattention in children. Studies showed that blood lead levels were highly correlated with neuropsychiatric disorders, and effects of neurotoxicity might persist and affect the incidence of neurodegenerative diseases, for example Alzheimer's disease (AD). OBJECTIVE: To explore possible mechanisms of developmental Pb-induced neuropsychiatric dysfunctions. METHODS: Children were divided into low blood lead level (BLL) group (0-50.00µg/L) and high BLL group (> 50.00µg/L) and blood samples were collected. miRNA array was used to testify miRNA expression landscape between two groups. Correlation analysis and real-time PCR were applied to find miRNAs that altered in Pb and neuropsychiatric diseases. Animal models and cell experiments were used to confirm the effect of miRNAs in response to Pb, and siRNA and luciferase experiments were conducted to examine their effect on neural functions. RESULTS: miRNA array data and correlation analysis showed that miR-34b was the most relevant miRNA among Pb neurotoxicity and neuropsychiatric disorders, and synapse-associated membrane protein 2 (VAMP2) was the target gene regulating synapse function. In vivo and in vitro studies showed Pb exposure injured rats' cognitive abilities and induced upregulation of miR-34b and downregulation of VAMP2, resulting in decreases of hippocampal synaptic vesicles. Blockage of miR-34b mitigated Pb's effects on VAMP2 in vitro. CONCLUSION: Early-life Pb exposure might exert synapse-toxic effects via inhibiting VAMP2 mediated by upregulation of miR-34b and shed a light on the underlying relationship between Pb neurotoxicity and developmental neuropsychiatric disorders.


Subject(s)
Lead , MicroRNAs , Animals , Humans , Lead/metabolism , Lead/toxicity , MicroRNAs/metabolism , Rats , Synapses/metabolism , Up-Regulation , Vesicle-Associated Membrane Protein 2/genetics , Vesicle-Associated Membrane Protein 2/metabolism
3.
Front Cell Dev Biol ; 9: 779373, 2021.
Article in English | MEDLINE | ID: mdl-34869383

ABSTRACT

The quiescence, activation, and subsequent neurogenesis of neural stem cells (NSCs) play essential roles in the physiological homeostasis and pathological repair of the central nervous system. Previous studies indicate that transmembrane protein Ttyh1 is required for the stemness of NSCs, whereas the exact functions in vivo and precise mechanisms are still waiting to be elucidated. By constructing Ttyh1-promoter driven reporter mice, we determined the specific expression of Ttyh1 in quiescent NSCs and niche astrocytes. Further evaluations on Ttyh1 knockout mice revealed that Ttyh1 ablation leads to activated neurogenesis and enhanced spatial learning and memory in adult mice (6-8 weeks). Correspondingly, Ttyh1 deficiency results in accelerated exhaustion of NSC pool and impaired neurogenesis in aged mice (12 months). By RNA-sequencing, bioinformatics and molecular biological analysis, we found that Ttyh1 is involved in the regulation of calcium signaling in NSCs, and transcription factor NFATc3 is a critical effector in quiescence versus cell cycle entry regulated by Ttyh1. Our research uncovered new endogenous mechanisms that regulate quiescence versus activation of NSCs, therefore provide novel targets for the intervention to activate quiescent NSCs to participate in injury repair during pathology and aging.

4.
Mol Brain ; 14(1): 129, 2021 08 21.
Article in English | MEDLINE | ID: mdl-34419133

ABSTRACT

Hypobaric hypoxia (HH) is a typical characteristic of high altitude environment and causes a spectrum of pathophysiological effects, including headaches, gliovascular dysfunction and cognitive retardation. Here, we sought to understand the mechanisms underlying cognitive deficits under HH exposure. Our results showed that hypobaric hypoxia exposure impaired cognitive function and suppressed dendritic spine density accompanied with increased neck length in both basal and apical hippocampal CA1 region neurons in mice. The expression of PSD95, a vital synaptic scaffolding molecule, is down-regulated by hypobaric hypoxia exposure and post-transcriptionally regulated by cold-inducible RNA-binding protein (Cirbp) through 3'-UTR region binding. PSD95 expressing alleviates hypoxia-induced dendritic spine morphology changes of hippocampal neurons and memory deterioration. Moreover, overexpressed Cirbp in hippocampus rescues HH-induced abnormal expression of PSD95 and attenuates hypoxia-induced dendritic spine injury and cognitive retardation. Thus, our findings reveal a novel mechanism that Cirbp-PSD-95 axis appears to play an essential role in HH-induced cognitive dysfunction in mice.


Subject(s)
Altitude Sickness/physiopathology , CA1 Region, Hippocampal/pathology , Cognition Disorders/prevention & control , Dendritic Spines/ultrastructure , Disks Large Homolog 4 Protein/physiology , RNA-Binding Proteins/physiology , 3' Untranslated Regions , Animals , Avoidance Learning , Base Sequence , Cells, Cultured , Cognition Disorders/etiology , Disks Large Homolog 4 Protein/biosynthesis , Disks Large Homolog 4 Protein/genetics , Gene Expression Regulation , Genes, Reporter , Genetic Vectors/administration & dosage , Memory Disorders/etiology , Memory Disorders/prevention & control , Mice , Mice, Inbred C57BL , Morris Water Maze Test , Neurons/physiology , Neurons/ultrastructure , Open Field Test , RNA-Binding Proteins/biosynthesis , RNA-Binding Proteins/genetics , Random Allocation , Recombinant Fusion Proteins/metabolism
5.
Environ Pollut ; 287: 117520, 2021 Oct 15.
Article in English | MEDLINE | ID: mdl-34182382

ABSTRACT

BACKGROUND: Neuroinflammation induced by lead exposure (Pb) is a major cause of neurotoxicity of Pb in the central nervous system (CNS). The NLR family, domain of pyrin containing 3 (NLRP3) involves in various neurological diseases, while the question of whether NLRP3 plays a role in lead-induced neuroinflammation has not yet been reported. METHODS: Developmental and knockout (KO) NLRP3 mice were used to establish two in vivo models, and BV2 cells were used to establish an in vitro model. Behavioral and electrophysiologic tests were used to assess the neurotoxicity of Pb, and immunofluorescence staining was used to assess neuroinflammation. Real-time PCR and western blot were performed to examine the mRNA and protein levels of inflammatory cytokines and NLRP3 inflammasomes. siRNA technology was used to block NLRP3 expression. RESULTS: Pb exposure led to neural injure and microglial activation in the hippocampus region, while minocycline intervention attenuated Pb-induced neurotoxicity by inhibiting neuroinflammation. Pb increased the expression of NLRP3 and promoted cleavage of caspase-1 in mRNA and protein levels, and minocycline partially reversed the effects of Pb on NLRP3 inflammasomes. Blocking of NLRP3 by KO mice or siRNA attenuated neural alterations induced by Pb, weakened microglial activation in vivo and in vitro as well, without affecting the accumulation of Pb. Pb increased autophagic protein levels and phosphorylation of NF-κB, while suppressing autophagy or NF-κB inhibited Pb's effects on NLRP3. CONCLUSIONS: NLRP3 is involved in the regulation of Pb-induced neurotoxicity. These findings expand mechanism research of Pb neurotoxicity and may help establish new prevention strategies for Pb neurotoxicity.


Subject(s)
Microglia , NLR Family, Pyrin Domain-Containing 3 Protein , Animals , Cytokines , Inflammasomes , Mice , NF-kappa B , NLR Family, Pyrin Domain-Containing 3 Protein/genetics
6.
Front Cell Dev Biol ; 9: 648261, 2021.
Article in English | MEDLINE | ID: mdl-33718391

ABSTRACT

Lead (Pb) can cause a significant neurotoxicity in both adults and children, leading to the impairment to brain function. Pb exposure plays a key role in the impairment of learning and memory through synaptic neurotoxicity, resulting in the cognitive function. Researches have demonstrated that Pb exposure plays an important role in the etiology and pathogenesis of neurodegenerative diseases, such as Alzheimer's disease. However, the underlying mechanisms remain unclear. In the current study, a gestational Pb exposure (GLE) rat model was established to investigate the underlying mechanisms of Pb-induced cognitive impairment. We demonstrated that low-level gestational Pb exposure impaired spatial learning and memory as well as hippocampal synaptic plasticity at postnatal day 30 (PND 30) when the blood concentration of Pb had already recovered to normal levels. Pb exposure induced a decrease in hippocampal glucose metabolism by reducing glucose transporter 4 (GLUT4) levels in the cell membrane through the phosphatidylinositol 3 kinase-protein kinase B (PI3K-Akt) pathway. In vivo and in vitro GLUT4 over-expression increased the membrane translocation of GLUT4 and glucose uptake, and reversed the Pb-induced impairment to synaptic plasticity and cognition. These findings indicate that Pb exposure impairs synaptic plasticity by reducing the level of GLUT4 in the cell membrane as well as glucose uptake via the PI3K-Akt signaling pathway, demonstrating a novel mechanism for Pb exposure-induced neurotoxicity.

7.
Medicine (Baltimore) ; 99(47): e23258, 2020 Nov 20.
Article in English | MEDLINE | ID: mdl-33217848

ABSTRACT

Amyotrophic lateral sclerosis (ALS), a specific neurodegenerative disease, imposed increased economic and utilizations burden on the healthcare system, especially with the progress of the diseases severity. However, the economic burden on Chinese ALS patients remained unclear. This study therefore was aimed to investigate medical cost and healthcare utilization for Chinese ALS patients.Longitudinal health data of over 20 million individuals, including military personnel and civilians, was collected from all Chinese military hospitals. We identified 480 patients with a first major diagnosis for ALS from 2015 to 2018, while matched 400 controlled patients on age, gender, ethnic group, geographic region, length of stay, year of diagnosis and comorbidity. Their medical cost and healthcare utilizations were then measured 1 year before, and 1 year after ALS diagnosis.The median annual medical cost of ALS patients was about 2-fold higher, 17,087 CNY during the index year than 1 year before, 7859 CNY. The highest increase in utilizations may account for medical costs on ALS patients, which was represented by hospitalizations (Odd Ratio (OR) = 4.26, 95% confidence interval (CI) 3.52, 5.15), electromyography (OR = 4.14, 95% CI 2.37, 7.22), nerve conduction velocity (OR = 3.26, 95% CI 2.23, 4.77).This study is the first one reporting direct economic burden on Chinese ALS patients. Efforts should be made to develop cost-effective diagnostic tools in order that sources of medical cost were more effectively allocated, and this disease was detected earlier.


Subject(s)
Amyotrophic Lateral Sclerosis/economics , Amyotrophic Lateral Sclerosis/therapy , Cost of Illness , Patient Acceptance of Health Care/statistics & numerical data , Adolescent , Adult , China , Cohort Studies , Female , Hospital Records , Humans , Male , Middle Aged , Time Factors , Young Adult
8.
Toxicol In Vitro ; 66: 104876, 2020 Aug.
Article in English | MEDLINE | ID: mdl-32344020

ABSTRACT

Previous studies reported perturbed expressing of X-linked inhibitor of apoptosis protein (XIAP) under lead (Pb) exposure. However, researches on XIAP expression mainly focused on its transcriptional and post-translational regulation, rarely involving post-transcriptional mechanism manipulated by certain indispensable microRNAs (miRNAs). Interestingly, we unveiled that miR-106b-5p, a widely expressed miRNA in various tissues, is up-regulated by Pb2+-induced stress. Moreover, we found a binding site for miR-106b-5p in the 3'-UTR of xiap mRNA using bioinformatics analysis, and provided the evidences that miR-106b-5p can interact and function with this regulatory region via luciferase reporter assay. Our results further showed that miR-106b-5p down-regulates XIAP protein level, and suppression of miR-106b-5p reverses the decrease in both XIAP level and cell viability in Pb2+-treated HT-22 and PC12 cells. In brief, we identified a novel function of miR-106b-5p in the post-transcriptional regulation of XIAP expression associated with Pb neurotoxicity.


Subject(s)
Environmental Pollutants/toxicity , Lead/toxicity , MicroRNAs , X-Linked Inhibitor of Apoptosis Protein/metabolism , Animals , Cell Line , Cell Survival/drug effects , Mice , RNA, Messenger/metabolism , Rats , X-Linked Inhibitor of Apoptosis Protein/genetics
9.
BMC Public Health ; 19(1): 1170, 2019 Aug 27.
Article in English | MEDLINE | ID: mdl-31455310

ABSTRACT

BACKGROUND: Though lead (Pb)-gasoline has been banned for decades in China, Pb continues to be a vital risk factor for various diseases. Traditional studies, without large sample size, were unable to identify explicitly the associations among Pb, its disease profile, and the related medical burden. This study was designed to investigate: 1) current status of blood Pb levels; 2) Pb-associated disease profile, medical burden, as well as impact factors. METHODS: Research subjects were patients who visited military hospitals and were required to test their blood Pb levels by doctors between 2013 and 2017. The large sample size and area coverage may, to a large extent, reveal the characteristics of Pb exposure in the whole Chinese population. Information of patients' electronic medical records was extracted using Structured Query Language (SQL) in Oracle database. The spatial, temporal, and population distribution of their blood Pb levels were tested, to illustrate the association of Pb exposure with diseases' profile, and medical burden. Non-parametric tests were applied to compare the differences of Pb levels among various groups. RESULTS: The blood Pb concentration showed a positively skewed distribution by Kolmogorov-Smirnov test (D = 0.147, p < 0.01). The blood Pb concentration of Chinese patients was 28.36 µg/L, with the lowest blood Pb levels, 4.71 µg/L, found in patients from Guangxi Zhuang Autonomous Region, and the highest, 50 µg/L, in Yunnan province. Han Chinese patients' Pb levels were significantly lower than other minorities groups (z-score = - 38.54, p < 0.01). Average medical cost for Pb poisoning was about 6888 CNY for Chinese patients. Pb levels of patients with malignant neoplasm of lung, 45.34 µg/L, were far higher than malignant neoplasm of other respiratory, and intrathoracic organs, 24.00 µg/L (z-score = - 2.79, p < 0.01). CONCLUSIONS: This study reported current status of blood Pb levels for patients who once visited military hospitals, partially representing the whole Chinese population. The result shows that Pb poisoning is still imposing marked economic burdens on patients under Pb exposure. Association of Pb with lung cancer may open up new areas for Pb-induced toxicology. The research strategy may advance toxicological studies in the aspect of medical data mining.


Subject(s)
Cost of Illness , Environmental Exposure/adverse effects , Ethnicity/statistics & numerical data , Lead Poisoning/ethnology , Lead/blood , Minority Groups/statistics & numerical data , Adolescent , Adult , Aged , Aged, 80 and over , Child , Child, Preschool , China/epidemiology , Female , Hospital Information Systems , Humans , Infant , Infant, Newborn , Lead/adverse effects , Lead Poisoning/economics , Lead Poisoning/therapy , Male , Middle Aged , Risk Factors , Young Adult
10.
Autophagy ; 13(5): 914-927, 2017 May 04.
Article in English | MEDLINE | ID: mdl-28318352

ABSTRACT

Central nervous system (CNS) inflammation and autophagy dysfunction are known to be involved in the pathology of neurodegenerative diseases. Manganese (Mn), a neurotoxic metal, has the potential to induce microglia-mediated neuroinflammation as well as autophagy dysfunction. NLRP3 (NLR family, pyrin domain containing 3)- CASP1 (caspase 1) inflammasome-mediated neuroinflammation in microglia has specific relevance to neurological diseases. However, the mechanism driving these phenomena remains poorly understood. We demonstrate that Mn activates the NLRP3-CASP1 inflammasome pathway in the hippocampus of mice and BV2 cells by triggering autophagy-lysosomal dysfunction. The autophagy-lysosomal dysfunction is induced by lysosomal damage caused by excessive Mn accumulation, damaging the structure and normal function of these organelles. Additionally, we show that the release of lysosomal CTSB (cathepsin B) plays an important role in Mn-induced NLRP3-CASP1 inflammasome activation, and that the increased autophagosomes in the cytoplasm are not the main cause of NLRP3-CASP1 inflammasome activation. The accumulation of proinflammatory cytokines, such as IL1B (interleukin 1 ß) and IL18 (interleukin 18), as well as the dysfunctional autophagy pathway may damage hippocampal neuronal cells, thus leading to hippocampal-dependent impairment in learning and memory, which is associated with the pathogenesis of Alzheimer disease (AD).


Subject(s)
Autophagy/drug effects , Caspase 1/metabolism , Hippocampus/drug effects , Learning/physiology , Memory Disorders/metabolism , Memory/physiology , NLR Family, Pyrin Domain-Containing 3 Protein/metabolism , Animals , Autophagy/physiology , Inflammasomes/drug effects , Inflammasomes/metabolism , Manganese/pharmacology , Mice
11.
Neurotoxicology ; 53: 153-164, 2016 Mar.
Article in English | MEDLINE | ID: mdl-26797587

ABSTRACT

Lead (Pb) is a ubiquitous environmental and industrial pollutant. It induces neurotoxicity and cell death by disrupting the pro- and anti-oxidative balance; however, the mechanisms of its toxicity have yet to be fully understood. The soy-derived isoflavonoid, genistein (GEN), was reported to possess neuroprotective and antioxidative properties. The present study investigated the molecular mechanisms of Pb-induced neurotoxicity in vivo and in vitro, addressing the efficacy of GEN in protecting against Pb-induced toxicity. Pb exposure was associated with reduction of cell viability and cell apoptosis, concomitant with reactive oxygen species (ROS) generation in vitro, and pre-treatment with GEN markedly ameliorated the Pb-induced oxidative injury by increasing the expression of key antioxidant enzymes and the antioxidant transcription factor, nuclear factor erythroid 2 p45-related factor 2 (Nrf2). Next, PKC-α activation was found after Pb exposure in vitro and pretreatment with GEN attenuated Pb-induced ROS generation by PKC-α inhibition. MAPK-NF-κB activation triggered by Pb was also inhibited by GEN. In summary, our study establishes that GEN alleviates Pb-induced impairment in spatial memory, and reduces cell apoptosis caused by Pb exposure and GEN protects neurons from Pb-induced neurotoxicity by downstream activation of antioxidant and anti-apoptotic pathways via regulation of Nrf2 and MAPK-NF-κB signaling.


Subject(s)
Genistein , Lead , Neuroprotective Agents , Neurotoxicity Syndromes , Signal Transduction , Animals , Male , Rats , Acetylcysteine/pharmacology , Catalase/metabolism , Disease Models, Animal , Dose-Response Relationship, Drug , Free Radical Scavengers/therapeutic use , Genistein/therapeutic use , In Situ Nick-End Labeling , Lead/toxicity , Maze Learning/drug effects , Mitogen-Activated Protein Kinase Kinases/metabolism , Neuroprotective Agents/therapeutic use , Neurotoxicity Syndromes/etiology , PC12 Cells/drug effects , Protein Kinase C/metabolism , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism , Signal Transduction/drug effects , Spatial Memory/drug effects , Superoxide Dismutase/metabolism , NF-E2-Related Factor 2/metabolism
12.
Toxicol In Vitro ; 29(5): 1185-94, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25975750

ABSTRACT

The blood-cerebrospinal fluid barrier (BCB) plays a critical role in the maintenance of optimal brain function. Tricellulin (TRIC), a protein localized at the tricellular contact sites of epithelial cells is involved in the formation of tight junctions in various epithelial barriers. However, little is known about its expression in the choroidal epithelial cells. It is well established that lead (Pb) exposure increases the leakage of the BCB. The purpose of this study is to investigate the expression and localization of TRIC in choroidal epithelial cells in vitro and whether altered TRIC expression mediates Pb-induced loss of barrier function. We found that TRIC protein and mRNA were expressed in choroidal epithelial cells in vitro and TRIC was localized at the tricellular contacts, colocalizing with occludin. Downregulation of TRIC by siRNA increased the BCB permeability corroborated by altered transendothelial electrical resistance (TEER) and FITC-dextran flux. Treatment with 10µM Pb reduced TRIC protein expression, but overexpression of TRIC alleviated the Pb-induced increase in BCB permeability. Bioinformatics analysis showed that mir-203 was a potential microRNA (miRNA) binding motif on TRIC 3'UTR, and that Pb exposure increased the expression of mir-203. Treatment with a mir-203 inhibitor increased TRIC protein expression and attenuated the Pb-induced BCB leakage. Our results establish that TRIC plays an important role in regulating BCB function.


Subject(s)
Choroid Plexus/metabolism , Epithelial Cells/metabolism , Lead/toxicity , MARVEL Domain Containing 2 Protein/metabolism , MicroRNAs/metabolism , Animals , Blood , Cell Line , Cerebrospinal Fluid , Choroid Plexus/cytology , MARVEL Domain Containing 2 Protein/genetics , Rats
13.
Oncotarget ; 5(16): 7126-37, 2014 Aug 30.
Article in English | MEDLINE | ID: mdl-25216527

ABSTRACT

The inhibitor of apoptosis protein XIAP (X-linked inhibitor of apoptosis protein) is a well-documented protein that is located in cytoplasm acting as a potent regulator of cell apoptosis. Here, we showed that expressing XIAP with RING (Really Interesting New Gene) domain deletion (XIAP△RING) in cancer cells promoted cancer cell anchorage-independent growth and G1/S phase transition companied with increasing cyclin e transcription activity and protein expression. Further studies revealed that XIAP△RING was mainly localized in nuclear with increased binding with E2F1, whereas XIAP with BIR (Baculoviral IAP Repeat) domains deletion (XIAP△BIRs) was entirely presented in cytoplasma with losing its binding with E2F1, suggesting that RING domain was able to inhibit BIR domains nuclear localization, by which impaired BIRs binding with E2F1 in cellular nucleus in intact cells. These studies identified a new function of XIAP protein in cellular nucleus is to regulate E2F1 transcriptional activity by binding with E2F1 in cancer cells. Our current finding of an effect of XIAP△RING expression on cancer cell anchorage-independent growth suggests that overexpression of this protein may contribute to genetic instability associated with cell cycle and checkpoint perturbations, in addition to its impact on cellular apoptosis.


Subject(s)
Colonic Neoplasms/metabolism , Colonic Neoplasms/pathology , Cyclin E/metabolism , E2F1 Transcription Factor/metabolism , X-Linked Inhibitor of Apoptosis Protein/metabolism , Apoptosis/physiology , Cell Adhesion/physiology , Cell Line, Tumor , Cell Nucleus/metabolism , Cell Proliferation/physiology , Cyclin E/genetics , Cytoplasm/metabolism , E2F1 Transcription Factor/genetics , G1 Phase/physiology , HCT116 Cells , Humans , Protein Structure, Tertiary , S Phase/physiology , Transfection , Up-Regulation , X-Linked Inhibitor of Apoptosis Protein/genetics
14.
Toxicol Lett ; 229(1): 158-66, 2014 Aug 17.
Article in English | MEDLINE | ID: mdl-24960059

ABSTRACT

miRNAs have been found to contribute to normal brain functions, nervous system diseases, as well as neurotoxicities induced by external agents. However, whether they are involved in lead-induced neurotoxicities is still not clear. To identify that, a lead-induced chronic neurotoxicity model of rats was built. Both miRNA microarray analysis and qRT-PCR were performed to determine the change of miRNA expression in hippocampus. Then 3 bioinformatics databases were used to analyze the relative target genes of these miRNA, which were further confirmed by qRT-PCR and Western blot. In the present study, lead exposure resulted in the changed expression of 7 miRNAs: miR-204, miR-211, miR-448, miR-449a, miR-34b, and miR-34c were greatly up-regulated while miR-494 was greatly down-regulated. Bioinformatics analysis results showed that the target genes of 6 up-regulated miRNAs were related to neural injury and neurodegeration, axon and synapse function, neural development and regeneration. Correspondingly, the expression levels of mature mRNAs and proteins of three target genes (Bcl-2, Itpr1, and Map2k1) were greatly repressed, verifying the results of bioinformatics analysis. Taken together, our results showed that the expression of several miRNAs reported to be associated with neurophysiological pathways and neurodegenerative diseases changed in rat hippocampus following chronic lead exposure. These miRNAs may play important roles in lead-induced neurotoxicity.


Subject(s)
Hippocampus/drug effects , Hippocampus/metabolism , Lead/toxicity , MicroRNAs/biosynthesis , Animals , Blotting, Western , Body Weight/drug effects , Computational Biology , Drinking/drug effects , Lead/blood , Male , Maze Learning/drug effects , Microarray Analysis , Nerve Regeneration/drug effects , Neurodegenerative Diseases/chemically induced , Neurodegenerative Diseases/genetics , Rats , Rats, Sprague-Dawley , Synapses/drug effects
15.
Mol Oncol ; 8(2): 285-96, 2014 Mar.
Article in English | MEDLINE | ID: mdl-24342356

ABSTRACT

Selective activation of Rho GTPase cascade requires the release of Rho from RhoGDI (GDP-dissociation inhibitors) complexes. Our previous studies identified RhoGDIα SUMOylation at Lys-138 and its function in the regulation of cancer cell invasion. In the current study, we demonstrate that RhoGDIα SUMOylation has a crucial role in the suppression of cancer cell anchorage-independent growth as well as the molecular mechanisms underlying this suppression. We found that ectopic expression of RhoGDIα resulted in marked inhibition of an anchorage-independent growth with induction of G0/G1 cell cycle arrest, while point mutation of RhoGDIα SUMOylation at residue Lys-138 (K138R) abrogated this growth suppression and G0/G1 cell cycle arrest in cancer cells. Further studies showed that SUMOylation at Lys-138 was critical for RhoGDIα down-regulation of cyclin D1 protein expression and that MEK1/2-Erk was a specific downstream target of SUMOylated RhoGDIα for its inhibition of C-Jun/AP-1 cascade, cyclin d1 transcription, and cell cycle progression. These results strongly demonstrate that SUMOylated RhoGDIα suppressed C-Jun/AP-1-dependent transactivation specifically via targeting MEK1/2-Erk, subsequently leading to the down-regulation of cyclin D1 expression and anti-cancer activity. Our results provide new mechanistic insights into the understanding of essential role of SUMOylation at Lys-138 in RhoGDIα's biological function.


Subject(s)
Cyclin D1/metabolism , G1 Phase Cell Cycle Checkpoints , Neoplasms/metabolism , Point Mutation , Sumoylation , rho Guanine Nucleotide Dissociation Inhibitor alpha/metabolism , Amino Acid Substitution , Cell Line, Tumor , Cyclin D1/genetics , Gene Expression Regulation, Neoplastic/genetics , Humans , MAP Kinase Signaling System/genetics , Neoplasms/genetics , Neoplasms/pathology , Proto-Oncogene Proteins c-jun/genetics , Proto-Oncogene Proteins c-jun/metabolism , Transcription, Genetic/genetics , rho Guanine Nucleotide Dissociation Inhibitor alpha/genetics
16.
Mol Cancer Ther ; 12(8): 1492-503, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23723126

ABSTRACT

Isorhapontigenin (ISO) is a new derivative of stilbene compound that was isolated from the Chinese herb Gnetum Cleistostachyum and has been used for treatment of bladder cancers for centuries. In our current studies, we have explored the potential inhibitory effect and molecular mechanisms underlying isorhapontigenin anticancer effects on anchorage-independent growth of human bladder cancer cell lines. We found that isorhapontigenin showed a significant inhibitory effect on human bladder cancer cell growth and was accompanied with related cell cycle G(0)-G(1) arrest as well as downregulation of cyclin D1 expression at the transcriptional level in UMUC3 and RT112 cells. Further studies identified that isorhapontigenin downregulated cyclin D1 gene transcription via inhibition of specific protein 1 (SP1) transactivation. Moreover, ectopic expression of GFP-cyclin D1 rendered UMUC3 cells resistant to induction of cell-cycle G(0)-G(1) arrest and inhibition of cancer cell anchorage-independent growth by isorhapontigenin treatment. Together, our studies show that isorhapontigenin is an active compound that mediates Gnetum Cleistostachyum's induction of cell-cycle G(0)-G(1) arrest and inhibition of cancer cell anchorage-independent growth through downregulating SP1/cyclin D1 axis in bladder cancer cells. Our studies provide a novel insight into understanding the anticancer activity of the Chinese herb Gnetum Cleistostachyum and its isolate isorhapontigenin.


Subject(s)
Antineoplastic Agents, Phytogenic/pharmacology , Cyclin D1/genetics , Gene Expression Regulation, Neoplastic/drug effects , Stilbenes/pharmacology , Urinary Bladder Neoplasms/genetics , Animals , Antineoplastic Agents, Phytogenic/pharmacokinetics , Binding Sites , Cell Cycle/drug effects , Cell Line, Tumor , Cell Proliferation/drug effects , Cyclin D1/metabolism , Disease Models, Animal , Down-Regulation , Humans , Male , Mice , Promoter Regions, Genetic , Sp1 Transcription Factor/metabolism , Stilbenes/pharmacokinetics , Transcription, Genetic/drug effects , Urinary Bladder Neoplasms/metabolism , Xenograft Model Antitumor Assays
17.
J Biol Chem ; 288(28): 20238-47, 2013 Jul 12.
Article in English | MEDLINE | ID: mdl-23720779

ABSTRACT

The X-linked inhibitor of apoptosis protein (XIAP) is a well known potent inhibitor of apoptosis; however, it is also involved in other cancer cell biological behavior. In the current study, we discovered that XIAP and its E3 ligase played a crucial role in regulation of cyclin D1 expression in cancer cells. We found that deficiency of XIAP expression resulted in a marked reduction in cyclin D1 expression. Consistently, cell cycle transition and anchorage-independent cell growth were also attenuated in XIAP-deficient cancer cells compared with those of the parental wild-type cells. Subsequent studies demonstrated that E3 ligase activity within the RING domain of XIAP is crucial for its ability to regulate cyclin D1 transcription, cell cycle transition, and anchorage-independent cell growth by up-regulating transactivation of c-Jun/AP-1. Moreover, we found that E3 ligase within RING domain was required for XIAP inhibition of phosphatase PP2A activity by up-regulation of PP2A phosphorylation at Tyr-307 in its catalytic subunit. Such PP2A phosphorylation and inactivation resulted in phosphorylation and activation of its downstream target c-Jun in turn leading to cyclin D1 expression. Collectively, our studies uncovered a novel function of E3 ligase activity of XIAP in the up-regulation of cyclin D1 expression, providing significant insight into the understanding of the biomedical significance of overexpressed XIAP in cancer development, further offering a new molecular basis for utilizing XIAP E3 ligase as a cancer therapeutic target.


Subject(s)
Cell Proliferation , Cyclin D1/metabolism , Protein Phosphatase 2/metabolism , Proto-Oncogene Proteins c-jun/metabolism , Ubiquitin-Protein Ligases/metabolism , X-Linked Inhibitor of Apoptosis Protein/metabolism , Binding Sites/genetics , Blotting, Western , Cell Adhesion , Colonic Neoplasms/genetics , Colonic Neoplasms/metabolism , Colonic Neoplasms/pathology , Cyclin D1/genetics , G1 Phase , Gene Expression Regulation, Neoplastic , HCT116 Cells , Humans , Mutation , Phosphorylation , Protein Phosphatase 2/genetics , Proto-Oncogene Proteins c-jun/genetics , RNA Interference , Reverse Transcriptase Polymerase Chain Reaction , S Phase , Transcription Factor AP-1/genetics , Transcription Factor AP-1/metabolism , Tyrosine/genetics , Tyrosine/metabolism , Ubiquitin-Protein Ligases/genetics , X-Linked Inhibitor of Apoptosis Protein/genetics
18.
Neurotox Res ; 24(4): 478-90, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23604964

ABSTRACT

The etiological role of dysregulated autophagy in neurodegenerative diseases has been a subject of intense investigation. While manganese (Mn) is known to cause dopaminergic (DAergic) neurodegeneration, it has yet to be determined whether the dysregulation of autophagy plays a role in Mn-induced neuronal injury. In this study, we investigated the effect of Mn on autophagy in a rat model of manganism, a neurodegenerative disease associated with excessive exposure to Mn. After a single intrastriatal injection of Mn, the short- (4-12 h) and long-term (1-28 days) effect of Mn on DAergic neurons and autophagy were examined. Marked reduction in the number of TH-immunoreactive neurons in the substantia nigra pars compacta (SNpc) as well as TH protein expression, and a significant increase of apomorphine-induced rotations were observed in rats after Mn injection. Manganese also induced the down-regulation of dopamine levels and D1 dopamine receptor expression. In addition, autophagy was dysregulated and inhibited, as evidenced by increased number of abnormal lysosomes, decreased protein expression of Beclin1, and decreased ratio of microtubule-associated protein 1 light chain 3 (LC3) II over LC3 I, concomitant with activated mammalian target of rapamycin (mTOR)/p70 ribosomal protein S6 kinase (p70s6k) signaling. In contrast, in the early phase of Mn exposure, the level of autophagy was not be suppressed but compensatorily activated. Although the morphology of the DAergic neuron was intact in the early phase, Mn caused a significant decrease in TH-immunoreactivity and a significant increase in apomorphine-induced rotations in the presence of wortmannin, an inhibitor of autophagy. Taken together, these results demonstrate, for the first time, that autophagy may play a protective role against Mn-induced neuronal damage, whilst dysregulation of autophagy at later phases may mediate DAergic neurodegeneration.


Subject(s)
Autophagy/drug effects , Dopaminergic Neurons/drug effects , Manganese/toxicity , Neurodegenerative Diseases/chemically induced , Substantia Nigra/drug effects , Animals , Disease Models, Animal , Dopaminergic Neurons/pathology , Locomotion/drug effects , Male , Neurodegenerative Diseases/pathology , Rats , Rats, Sprague-Dawley , Substantia Nigra/pathology , Substantia Nigra/ultrastructure
19.
Neurotoxicology ; 33(4): 780-8, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22406923

ABSTRACT

Increasing evidence indicates that neuroinflammation plays an important role in neurotoxins-induced neurodegenerations. Microglia are a type of glial cells in the brain and play as the first and main form of active immune defense in the central nervous system. Accumulated data suggest that the activation of microglia plays a critical role in neurotoxicities induced by environmental toxicants. So the inhibition of microglia has been proven to be an effective strategy against neurotoxic effects. In the present study, we found that n-3 polyunsaturated fatty acids can inhibit both microglial activation and dopaminergic injury in the substantia nigra of Sprague-Dawley rats induced by lipopolysaccharide, one of the major constituents of the outer membrane of Gram-negative bacteria. Moreover, n-3 polyunsaturated fatty acids inhibited lipopolysaccharide-induced activation of nuclear factor-κB, an important transcription factor involved in microglial activation. Taken together, our results provided the first in vivo evidence that n-3 polyunsaturated fatty acids can inhibit the damage of dopaminergic neurons induced by lipopolysaccharide through their inhibitory effects on nuclear factor-κB-dependent microglial activation.


Subject(s)
Docosahexaenoic Acids/pharmacology , Dopaminergic Neurons/drug effects , Eicosapentaenoic Acid/pharmacology , Lipopolysaccharides , Microglia/drug effects , Neuroprotective Agents/pharmacology , Parkinsonian Disorders/prevention & control , Substantia Nigra/drug effects , Animals , Behavior, Animal/drug effects , Cytoprotection , Disease Models, Animal , Dopaminergic Neurons/metabolism , Dopaminergic Neurons/pathology , Male , Microglia/metabolism , Microglia/pathology , Motor Activity/drug effects , NF-kappa B/metabolism , Nerve Degeneration , Parkinsonian Disorders/chemically induced , Parkinsonian Disorders/metabolism , Parkinsonian Disorders/pathology , Parkinsonian Disorders/physiopathology , Rats , Rats, Sprague-Dawley , Substantia Nigra/metabolism , Substantia Nigra/pathology , Substantia Nigra/physiopathology , Tyrosine 3-Monooxygenase/metabolism
20.
Wei Sheng Yan Jiu ; 40(1): 95-8, 2011 Jan.
Article in Chinese | MEDLINE | ID: mdl-21434324

ABSTRACT

OBJECTIVE: To study the inhibition effect of equol on MDA-MB-231 cells, a human breast cancer cell line with estrogen-independent receptor. METHODS: Cultured MDA-MB-231 cells were treated with different contents of equol. The cell viability was assessed with MTT method. The apoptosis was detected by flow cytometry and immunofluorescence. Western Blot was used to assess the expression of NF-kappaB. RESULTS: The growth of MDA-MB-231 cells was inhibited by equol in a does-and time-dependent manner. The apoptosis of MDA-MB-231 cells induced by equol was the result of inhibiting the expression of NF-kappaB. CONCLUSION: The apoptosis of MDA-MB-231 cells might be the reduced expression of NF-kappaB induced by equol.


Subject(s)
Apoptosis/drug effects , Breast Neoplasms/pathology , Equol/pharmacology , NF-kappa B/metabolism , Antineoplastic Agents, Phytogenic/pharmacology , Breast Neoplasms/metabolism , Cell Line, Tumor , Female , Humans , Phytoestrogens/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...